1) BS_ prefix for bloodstage drug converted to CQ_ for consistency with other treatment
2) Added a G6PD diagnostic layer on top of actual G6PD activity reading
3) Added a 'third gender' to reflect peri-domestic vs occupational exposure in M, and F (single value)